Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Nutrients
Volume 9, Issue 4, Pages 394
Publisher
MDPI AG
Online
2017-04-18
DOI
10.3390/nu9040394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology
- (2016) María José Ferri et al. PLoS One
- Association Between Pancreatitis and Subsequent Risk of Pancreatic Cancer: a Systematic Review of Epidemiological Studies
- (2014) Gui-Xian Tong et al. Asian Pacific Journal of Cancer Prevention
- Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWO
- (2014) Philip A. Philip et al. CANCER
- Cholelithiasis and risk of pancreatic cancer: systematic review and meta-analysis of 21 observational studies
- (2014) Yuanfeng Gong et al. CANCER CAUSES & CONTROL
- Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies
- (2014) Eric J. Jacobs et al. CANCER CAUSES & CONTROL
- Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
- (2014) Ramadevi Subramani et al. PLoS One
- Putative Predictive Biomarkers of Survival in Patients with Metastatic Pancreatic Adenocarcinoma Treated with Gemcitabine and Ganitumab, an IGF1R Inhibitor
- (2013) I. McCaffery et al. CLINICAL CANCER RESEARCH
- Insulin-like growth factor-I (IGF-I) and clinical nutrition
- (2013) Callum Livingstone CLINICAL SCIENCE
- Non-linear dose–response relationship between cigarette smoking and pancreatic cancer risk: Evidence from a meta-analysis of 42 observational studies
- (2013) Li Zou et al. EUROPEAN JOURNAL OF CANCER
- A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
- (2012) H. L. Kindler et al. ANNALS OF ONCOLOGY
- Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition
- (2012) S Rohrmann et al. BRITISH JOURNAL OF CANCER
- Gastrectomy and risk of pancreatic cancer: systematic review and meta-analysis of observational studies
- (2012) Yuanfeng Gong et al. CANCER CAUSES & CONTROL
- Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis
- (2012) Feng Chi et al. MOLECULAR BIOLOGY REPORTS
- BMS-754807, a Small-Molecule Inhibitor of Insulin-like Growth Factor-1 Receptor/Insulin Receptor, Enhances Gemcitabine Response in Pancreatic Cancer
- (2012) N. Awasthi et al. MOLECULAR CANCER THERAPEUTICS
- Clinical Value of Circulating Lipocalins and Insulin-Like Growth Factor Axis in Pancreatic Cancer Diagnosis
- (2012) Hala O. El-Mesallamy et al. PANCREAS
- Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis
- (2012) Hongxin Cao et al. PLoS One
- Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)
- (2011) C. Bosetti et al. ANNALS OF ONCOLOGY
- Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose–response meta-analysis of prospective studies
- (2011) D. Aune et al. ANNALS OF ONCOLOGY
- Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies
- (2011) Genlai Lin et al. CANCER CAUSES & CONTROL
- Anthropometric Measures, Body Mass Index, and Pancreatic Cancer
- (2010) Alan A. Arslan ARCHIVES OF INTERNAL MEDICINE
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
- (2010) Sara Raimondi et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 Molar Ratio and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- (2010) J. B. Douglas et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- StatBite U.S. Pancreatic Cancer Rates
- (2010) JNCI-Journal of the National Cancer Institute
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
- (2010) LANCET ONCOLOGY
- Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies
- (2009) Sabina Rinaldi et al. INTERNATIONAL JOURNAL OF CANCER
- IGF-I and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested case-control studies
- (2009) Bo Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis
- (2008) Christian Moser et al. EUROPEAN JOURNAL OF CANCER
- Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
- (2008) Mari-Anne Rowlands et al. INTERNATIONAL JOURNAL OF CANCER
- New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
- (2008) Rahul Pannala et al. LANCET ONCOLOGY
- Tobacco and the risk of pancreatic cancer: a review and meta-analysis
- (2008) Simona Iodice et al. LANGENBECKS ARCHIVES OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More